A case of ductal carcinoma in situ (DCIS) with markedly elevated CA15-3 levels requiring 2 years of diagnosis
Abstract Background CA15-3 is often elevated in breast cancer recurrence and rarely in ductal carcinoma in situ (DCIS). We report a case of DCIS with elevated CA15-3 levels, which was diagnosed after over 2 years of follow-up. Case presentation A 74-year-old woman presented with a left-sided breast...
Main Authors: | Mutsumi Fujimoto, Yoshie Kobayashi, Kazuya Kuraoka, Tomoyuki Yoshiyama, Hideo Shigematu |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-12-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40792-023-01792-8 |
Similar Items
-
Ductal carcinoma in situ (DCIS) in breast fibroadenoma
by: Manar El-Essawy, et al.
Published: (2020-05-01) -
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
by: Fredrik Wärnberg, et al.
Published: (2021-12-01) -
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
by: Francesca Magnoni, et al.
Published: (2023-05-01) -
Is palpable DCIS more aggressive than screen-detected DCIS?
by: Nina Balac, et al.
Published: (2023-01-01) -
Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up
by: Domenico Cante, et al.
Published: (2022-06-01)